Innovation versus Financialization in the US Pharmaceutical Industry

Tulum, Oner (The Academic-Industry Research Network), Lazonick, William (The Academic-Industry Research Network)

Description

The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a) should have their drug prices regulated, (b) use their profits to distribute cash dividends and stock buybacks; (c) do not rely on investment by shareholders; and (d) benefit from 'collective and cumulative learning.'
€ 31,15
Paperback / softback
 
Free shipping from
€ 19,95 within The Netherlands
Writer
Tulum, Oner (The Academic-Industry Research Network), Lazonick, William (The Academic-Industry Research Network)
Title
Innovation versus Financialization in the US Pharmaceutical Industry
Publisher
Cambridge University Press
Year
2025
Language
English
Pages
96
EAN
9781009707985
Binding format
Paperback / softback

You will always receive the last edition from us!


Categories

Boekstra